Interstitial Lung Diseases
Respiratory Critical Care
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
ERJ Open Research
European Lung White Book
All ERS guidelines
Global Lung Function Initiative
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
Courses and events
ADME properties of a novel PI3Kd inhibitor, DS-1515, in preclinical studies
Y. Nishiya (Tokyo, Japan), T. Honda (Tokyo, Japan), K. Itokawa (Tokyo, Japan), O. Ando (Tokyo, Japan), M. Suzuki (Tokyo, Japan), K. Morimoto (Tokyo, Japan)
International Congress 2018 – Basic pharmacology
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Y. Nishiya (Tokyo, Japan), T. Honda (Tokyo, Japan), K. Itokawa (Tokyo, Japan), O. Ando (Tokyo, Japan), M. Suzuki (Tokyo, Japan), K. Morimoto (Tokyo, Japan). ADME properties of a novel PI3Kd inhibitor, DS-1515, in preclinical studies. 1053
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
No comment yet.
to comment this presentation.
Related content which might interest you:
Incorrect inhaler technique is common in patients with COPD – Data from the TIE study
A prospective study of the effect of carbocysteine lysine salt on COPD exacerbations with or without inhaled steroids
The novel elastase inhibitor BAY 85-8501 provides a new approach in the treatment of pulmonary diseases